Thieme E-Books & E-Journals -
Back
Synlett 2013; 24(3): 323-326
DOI: 10.1055/s-0032-1317919
cluster
© Georg Thieme Verlag Stuttgart · New York

Process Development of Halaven®: Synthesis of the C1–C13 Fragment from d-(–)-Gulono-1,4-lactone

Charles E. Chase
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
,
Francis G. Fang
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
,
Bryan M. Lewis*
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
,
Gordon D. Wilkie
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
,
Matthew J. Schnaderbeck
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
,
Xiaojie Zhu
Pharmaceutical Science & Technology, Eisai Product Creation Systems, Eisai Inc., 4 Corporate Drive, Andover, MA 01810-2441, USA   Fax: +1(978)7944910   Email: Bryan_Lewis@eisai.com
› Author Affiliations